--- title: "Breakthroughs Made in Understanding Genetic Link Between Alzheimer's Disease and APOE4 Gene" url: https://noti.group/breakthroughs-made-in-understanding-genetic-link-between-alzheimer/ language: en publisher: "Noti Group" section: "Health" published: 2026-10-01T04:45:26.000Z updated: 2026-10-02T02:23:17.094Z id: bedc6418-7e4f-4f04-a39b-e7832aff8038 source: "ScienceDaily Health https://www.sciencedaily.com/releases/2026/09/260930225450.htm" attribution: "Link to https://noti.group/breakthroughs-made-in-understanding-genetic-link-between-alzheimer/ and name Noti Group when you quote or summarize this story." --- # Breakthroughs Made in Understanding Genetic Link Between Alzheimer's Disease and APOE4 Gene Researchers at Mount Sinai have made significant breakthroughs in understanding the genetic link between Alzheimer's disease and the APOE4 gene. The strongest known risk factor for Alzheimer's, APOE4 can damage blood vessels in the brain and contribute to the accumulation of abnormal proteins associated with neurodegenerative diseases. Alzheimer's disease is a devastating condition that affects memory, thinking, and behavior in millions of older adults worldwide. In the United States alone, over 7 million people suffer from this debilitating illness. For years, researchers have known that blood vessels in the brain deteriorate as Alzheimer's progresses, particularly in individuals carrying the APOE4 gene. The role of vascular damage in Alzheimer's disease has long been a subject of debate among scientists. While it was previously thought to be a consequence of the disease, new evidence suggests that it may actually contribute directly to its progression. This uncertainty has hindered efforts to develop effective treatments for the condition. Mount Sinai researchers have developed a detailed map of gene activity in human brain blood vessels using existing datasets and cutting-edge technology. The resulting atlas provides a comprehensive view of how APOE4 contributes to vascular degeneration, shedding light on the disease processes involved. The study's findings have significant implications for the development of treatments that target Alzheimer's disease at its root cause. By understanding how APOE4 damages brain blood vessels and promotes abnormal protein accumulation, scientists may be able to identify new therapeutic targets and develop more effective interventions. The research team has made a significant discovery regarding the APOE4 gene, which is associated with an increased risk of Alzheimer's disease. They found that this gene alters the behavior of pericytes, cells that play a crucial role in stabilizing small blood vessels and supporting the blood-brain barrier. In the presence of APOE4, these pericytes transform into myofibroblast-like cells that produce scar tissue. This transformation leads to vascular fibrosis, which is characterized by the accumulation of abnormal protein around blood vessels. This buildup can interfere with blood flow and create conditions conducive to neurodegeneration. The researchers have also found evidence that this process may be reversible. By blocking TGF-β signaling, a key component in cell communication and tissue remodeling, they were able to restore pericyte coverage while reducing fibrosis and amyloid accumulation around blood vessels. This finding suggests that the vascular degeneration associated with APOE4 is not an irreversible consequence of Alzheimer's disease but rather a biologically active process that can be reversed. The study's results provide new insights into potential therapeutic targets for preserving vascular function and limiting abnormal protein buildup. The researchers used aged APOE4 mice to replicate their findings, demonstrating the potential for therapeutic reversal of vascular degeneration in this model. This breakthrough has significant implications for the development of treatments aimed at protecting the brain's circulation in individuals with a high genetic risk for Alzheimer's disease. The study's authors suggest that blocking TGF-β signaling could be a viable therapeutic strategy for preventing or reversing the vascular damage associated with APOE4. Further research is needed to explore this possibility and develop effective interventions for mitigating the risks of Alzheimer's disease in individuals carrying this gene variant. The development of three-dimensional human brain tissue, known as miBrains, has been crucial in understanding the effects of the APOE4 gene variant on the brain. This model, created from induced pluripotent stem cells by a team at Mount Sinai, replicates key features of human brain tissue, including its intricate network of blood vessels. Combining findings from miBrains with data from preclinical models, postmortem human brain tissue, and transcriptomic analysis has provided a more comprehensive understanding of the mechanisms underlying APOE4's influence on the brain. Each approach has reinforced and expanded upon observations made using other methods. By integrating these systems, researchers have been able to recreate events that occur before severe vascular abnormalities develop in human brain tissue after death. This has allowed them to identify the key factors behind these changes and test potential treatments. In a related study published in Cell Stem Cell, scientists used miBrains to investigate another effect of APOE4: its role in the accumulation of abnormal proteins associated with neurodegenerative diseases. The buildup of abnormal proteins is a hallmark of conditions such as Alzheimer's and Parkinson's disease, but studying this process within a living human brain is extremely challenging. The miBrain system provides a unique opportunity to observe related processes in complex human brain-like tissue under laboratory conditions. The accumulation of alpha-synuclein in brain cells is a significant concern for neurodegenerative diseases like Alzheimer's and Parkinson's. Researchers have been trying to understand the cellular processes that lead to this accumulation, but many questions remain unanswered. A crucial aspect of this process appears to be cholesterol buildup inside astrocytes. These support cells are essential for maintaining brain health by performing various functions. The excess cholesterol disrupts the lysosomal waste-disposal system in these cells, making them less effective at breaking down alpha-synuclein. As a result, the protein accumulates and spreads to neurons, contributing to toxic deposits. This discovery suggests that cholesterol metabolism inside astrocytes and lysosomal function could be critical targets for treating neurodegenerative diseases. The miBrain system has provided valuable insights into this process by allowing researchers to follow the chain of events in complex human brain-like tissue. Researchers at Mount Sinai are developing brain tissue models called miBrains from individual patients, allowing them to investigate how neurodegenerative diseases develop uniquely in each person. These personalized miBrain models will enable scientists to study the progression of neurodegenerative diseases and test potential treatments more efficiently. This could help bridge the gap between laboratory discoveries and actual treatments for a wide range of disorders. The development of miBrains is part of Mount Sinai's ongoing research into various aspects of neurodegenerative disease, including vascular degeneration in the brain. A recent study published in Cell received support from several organizations, including NASA and the National Institute on Aging at the National Institutes of Health. Another study examining abnormal protein buildup in the brain was also supported by these same organizations, as well as the Michael J. Fox Foundation for Parkinson's Research and the CureAlz Fund. The SWT Foundation provided funding for both studies. These ongoing research efforts are expected to provide valuable insights into the development and progression of neurodegenerative diseases, ultimately leading to more effective treatments and therapies. Research has revealed that the APOE4 gene, often linked to an increased risk of Alzheimer's disease, may have a reversible weakness. This discovery is significant as it could potentially lead to new avenues for treatment and therapy development. The study found that the APOE4 gene can be affected by dietary changes, which in turn may impact its function. This finding suggests that lifestyle modifications, such as adopting a specific eating pattern, may help mitigate the effects of this gene. The potential implications of this research are far-reaching, with ongoing studies aiming to uncover more about the relationship between diet and genetic factors contributing to neurodegenerative diseases. --- Source: [ScienceDaily Health](https://www.sciencedaily.com/releases/2026/09/260930225450.htm) Published by Noti Group: https://noti.group/breakthroughs-made-in-understanding-genetic-link-between-alzheimer/